Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Clinical trial NCT05285358 · RECRUITING

Trial details

NCT number: NCT05285358
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Distal Bile Duct Adenocarcinoma Gallbladder Carcinoma Intrahepatic Cholangiocarcinoma Metastatic Malignant Neoplasm in the Peritoneum Stage IV Distal Bile Duct Cancer AJCC v8 Stage IV Intrahepatic Bile Duct Cancer AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Stage IVB Gallbladder Cancer AJCC v8

Start date: 2022-09-19
Primary completion: 2028-10-11
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.